@misc{indiciae15370da1b3d3,
  title = {Cancer phase I trial design using drug combinations when a fraction of dose limiting toxicities is attributable to one or more agents},
  author = {Jose L. Jimenez and Mourad Tighiouart and Mauro Gasparini},
  year = {2018},
  doi = {10.1002/bimj.201700166},
  url = {https://arxiv.org/abs/1709.00918},
  note = {Source identifier: 1709.00918}
}